| EPIC |
BVXP |
| Sector |
Pharma and Biotech |
| ISIN |
GB00B4QVDF07 |
| Market Sector |
AIM |
| Market Segment |
ASQ1 |
| Main Indices |
FTSE AIM All-Share, FTSE AIM 100 |
| Country of register |
Great Britain |
| Currency |
British Pound |
| Market Cap |
£108.42m |
| NMS |
200 |
| Shares in issue |
5.22m |
| Date Listed |
29-Apr-2014 |
| |
2nd Interim |
1st Interim |
| Ex-Div |
06-Nov-25 |
10-Apr-25 |
| Paid |
21-Nov-25 |
25-Apr-25 |
| Amount |
80.00p |
70.00p |
| 16:04 |
38 @ 2,091.00p |
| 15:50 |
47 @ 2,091.00p |
| 15:49 |
181 @ 2,050.00p |
| 15:24 |
256 @ 2,092.00p |
| 14:33 |
181 @ 2,075.00p |
| CEO |
Peter John Harrison |
| Chair |
Ian James Nicholson |
| CFO |
Bruce Hiscock |
Top of Page
You are here:
research